This session will explore how genomics can be systematically integrated into routine healthcare to improve patient outcomes and support more personalised care. Discussions will examine the workforce transformation needed to embed genomic medicine across health systems, including upskilling primary care providers and equipping multidisciplinary teams with the knowledge and tools to use genomic information effectively. The session will also highlight the digital infrastructure required to support implementation, with a focus on integrating genomics into electronic health records and embedding clinical decision support into everyday workflows. Drawing on real-world implementation experience, speakers will share practical lessons and explore how technology is helping make genomic medicine a sustainable and scalable part of clinical care.

Genomic newborn screening is at a pivotal moment as healthcare systems transition from research and pilot programmes to clinical implementation. This session will explore the opportunities and challenges of integrating genomic sequencing into newborn screening, including decisions about which conditions to screen, how to manage uncertain or incidental findings, and the responsibilities for long-term follow-up and care. Drawing on experiences from programmes at different stages of implementation, speakers will share practical lessons and discuss how international collaboration and emerging standards can support equitable, effective, and sustainable genomic newborn screening across diverse health systems.

13:05 PM - 13:30 PM • Grand Ballroom
“Gene Level Variant Harmonization as the Foundation for Standardized Genomic Screening”
Dr. Theo Heyns (Illumina)

13:05 PM - 13:30 PM • Read & Spottiswoode
“Partnering with Genome Canada on the Canadian Precision Health Initiative” 
by Dr. Étienne Richer, Genome Canada

13:30 PM - 13:55 PM • Read & Spottiswoode
“Powering Population Genomics and Clinical Sequencing at Scale: a Lucence, Qiagen, and Ultima Partnership to Support Genomics in Singapore” 
by Dr. Min-Han Tan (Lucence), Mr. Meng Earn Lim (Qiagen), and Dr. Francisco De La Vega (Ultima Genomics)

Population genomic screening is transitioning from pilot studies to national policy discussions. This session draws on real-world policy experience from early-adopter health systems to examine the regulatory frameworks, reimbursement models, and ethical guardrails that will determine whether that transition happens equitably and sustainably.

This closing talk show takes a deliberately aspirational tone, asking what must change in technologies, care models, and health systems over the next decade in order for genomic medicine to fulfill its promise, and where international collaboration and standards can proactively guide responsible innovation. Hosted by freelance science journalist Sandy Ong, the aim is a free-ranging conversation among people who have thought seriously about where the field is headed.

Explore posters showcasing community work across genomic data sharing, standards implementation, and emerging initiatives, while connecting with presenters and fellow attendees over refreshments.